查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1916227

可吸收聚乳酸材料市场：按产品类型、技术、等级、最终用户和应用划分 - 全球预测（2026-2032）

Resorbable Polylactic Acid Material Market by Product Type, Technology, Grade, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，可吸收聚乳酸材料市场价值将达到 13.6 亿美元，到 2026 年将成长至 14.4 亿美元，到 2032 年将达到 19.9 亿美元，年复合成长率为 5.54%。

关键市场统计数据
基准年 2025 13.6亿美元
预计年份：2026年 14.4亿美元
预测年份 2032 19.9亿美元
复合年增长率 (%) 5.54%

本文简要介绍了影响可吸收聚乳酸材料的临床、生产和监管因素及其在先进医疗应用中的作用。

生物可降解聚乳酸材料在聚合物科学与医疗创新领域发挥关键作用，其可预测的生物降解特性和广泛的加工选择，能够支援客製化器械结构。临床应用范围涵盖临时结构支撑到药物控释，而该材料的可调控特性使其在需要梯度载荷传递和生物相容性吸收的场合极具吸引力。过去十年，立体化学、分​​子量分布和共聚策略的进步拓展了其性能范围，同时也使其能够相容于积层製造（3D列印）和传统加工製程。

变革性变化正在重塑医疗保健领域可吸收聚乳酸材料的供应链、创新流程和临床应用路径。

生物可吸收聚乳酸材料领域正经历变革性的转变，这主要得益于加工技术的创新、临床需求的转变以及供应链的策略重组。积层製造和精密挤出技术能够实现以往难以企及的复杂几何形状和多孔结构，从而支持製造具有可控降解速率的个人化植入和支架。同时，聚合物化学的进步以及先进的灭菌技术正在降低器械的差异性，并扩大可吸收材料的安全适应症范围。

评估 2025 年美国对可吸收聚乳酸的生产和分销征收关税的累积经济、营运和供应链影响。

2025年公布的关税政策为依赖单体、特殊聚合物和成品可吸收聚乳酸组件国际分销的製造商、供应商和医疗设备公司的营运成本会计带来了新的复杂性。更高的进口关税和某些聚合物中间体的重新分类正在影响筹资策略，导致到岸成本上升，并促使企业在地采购和关键材料的近岸外包。为此，采购部门正在调整其供应商组合，优先考虑地理多样性、合约柔软性以及上游原材料供应情况的透明度。

可操作的细分洞察，揭示应用、产品类型、技术、最终用户和等级如何影响开发重点和商业化策略。

这种细分方法为理解材料性能和加工方法的选择如何在产品生命週期和最终用途需求中创造最大价值提供了一个实用框架。本研究分析了以下应用领域：药物传输（包括植入式和注射装置）；整形外科器械（包括钢钉、钢板和螺丝）；组织工程（包括水凝胶和支架应用）；以及伤口缝合（包括缝合钉和缝线）。研究检验了每种应用如何带来独特的机械性能、降解特性和监管要求，从而影响聚合物的选择和加工路线。按产品类型划分，本研究区分了聚乳酸的主要物理形态——纤维、长丝、薄膜和颗粒——并重点介绍了每种形态在下游製造工艺和功能性能方面的不同可能性。

美洲、欧洲、中东和非洲以及亚太地区可吸收聚乳酸（PALA）应用及供应韧性的区域趋势和战略机会

区域趋势对采购、监管沟通和临床试验规划的策略选择有显着影响。在美洲，接近性大规模临床网路和强大的医疗设备製造商生态系统有利于从研究到临床实践的快速转化，但相关人员必须认真考虑复杂的监管环境，该环境强调可靠的临床证据和上市后监测。在欧洲、中东和非洲，监管协调工作和成熟的医疗设备市场为标准化产品的引入创造了机会。同时，新兴需求地区鼓励建立灵活的生产结构和区域伙伴关係，以适应当地的采购通讯协定。

提供有关领先製造商、创新者和策略联盟的竞争情报，这些企业正在塑造可吸收聚乳酸产品和技术能力的未来。

可吸收聚乳酸领域的竞争格局主要由三种类型构成：从聚合物生产到器械组装实现垂直整合的製造商；专注于高纯度聚合物和先进加工製程的专业供应商；以及开发底层加工技术和配方的创新技术提供者。在这些类型中，差异化越来越依赖能否证明材料性能的稳定性、可记录的降解行为以及符合可追溯性和无菌性监管要求的生产流程。

产业领导者加速创新、降低供应风险和优化可吸收聚乳酸临床路径的实际优先事项

产业领导者应优先考虑一系列切实可行的倡议，以加速技术应用并减少实用化过程中的阻力。首先，在设计过程早期就应将材料开发与预期的临床应用案例相匹配，确保聚合物性能、加工方法和灭菌技术均检验临床性能标准。这种领先配对能够减少临床证据产生过程中的设计变更週期，并缩短监管审批流程。

透明的调查方法，详细说明了用于分析可吸收聚乳酸产业趋势的资料来源、定性和定量方法以及检验方法。

本调查方法结合了对同行评审文献的系统性回顾、监管指导文件的分析以及对材料科学、医疗设备工程、临床实践和供应链管理领域专家的定性访谈。主要研究包括对研发总监、品质和法规专家以及采购负责人进行结构化访谈，以了解影响研发和商业策略的实际限制因素和决策标准。二级资讯来源包括技术文献、标准机构指南和公开的监管文件，以对材料特性、加工行为和已记录的临床结果进行三角验证。

对相关人员的策略需求进行关键性综合分析，以协调材料创新和监管路径，从而加速可吸收聚乳酸的临床应用。

这项综合分析着重指出了相关人员在寻求利用可吸收聚乳酸材料潜力时面临的三大相互关联的关键挑战：技术严谨性、供应链韧性和监管完整性。技术严谨性意味着建立可重复的聚合物性能和加工通讯协定，从而转化为可预测的体内性能。这需要对分析表征、降解曲线分析和製程控制进行投入，并且这些工作必须儘早记录并持续到规模化生产过程中。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 可吸收聚乳酸材料市场（依产品类型划分）

  • 纤维
  • 灯丝
  • 电影
  • 颗粒

9. 依技术分類的可吸收聚乳酸材料市场

  • 3D列印
  • 挤压
  • 射出成型
  • 溶剂浇铸

第十章 可吸收聚乳酸材料市场（依等级划分）

  • 医用级
  • 医药级

第十一章 可吸收聚乳酸材料市场（以最终用户划分）

  • 诊所
  • 医院
  • 製药公司
  • 研究所

第十二章 可吸收聚乳酸材料市场（依应用领域划分）

  • 药物输送
    • 植入式医疗器材
    • 注射装置
  • 整形外科器械
    • 别针
    • 盘子
    • 拧紧
  • 组织工程
    • 水凝胶
    • 鹰架
  • 伤口缝合
    • 史泰博
    • 缝合线

第十三章 可吸收聚乳酸材料市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 可吸收聚乳酸材料市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国可吸收聚乳酸材料市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国可吸收聚乳酸材料市场

第十七章 中国吸水性聚乳酸材料市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Chongqing Jindan Bio-Technology Co., Ltd.
  • Corbion NV
  • Evonik Industries AG
  • FKuR Kunststoff GmbH
  • Mitsui Chemicals, Inc.
  • NatureWorks LLC
  • Shenzhen Esun Industrial Co., Ltd.
  • Synbra Technology NV
  • TotalEnergies Corbion BV
  • Unitika Ltd.
  • Zhejiang Hisun Biomaterials Co., Ltd.
Product Code: MRR-AE420CB15319

The Resorbable Polylactic Acid Material Market was valued at USD 1.36 billion in 2025 and is projected to grow to USD 1.44 billion in 2026, with a CAGR of 5.54%, reaching USD 1.99 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.36 billion
Estimated Year [2026] USD 1.44 billion
Forecast Year [2032] USD 1.99 billion
CAGR (%) 5.54%

A concise introduction to clinical, manufacturing, and regulatory forces shaping resorbable polylactic acid materials and their role in advanced medical applications

Resorbable polylactic acid materials occupy a pivotal role at the intersection of polymer science and medical innovation, offering predictable biodegradation profiles and a broad suite of processing options that support bespoke device architectures. Clinical applications span temporary structural support to controlled drug release, and the material's tunable properties make it attractive where gradual load transfer and biocompatible resorption are required. Over the past decade, advances in stereochemistry control, molecular weight distribution, and copolymerization strategies have expanded performance envelopes while enabling compatibility with additive manufacturing and conventional processing routes.

Manufacturers and clinical developers must navigate a layered regulatory environment where biocompatibility data, sterilization compatibility, and traceability are core requirements. Concurrently, supply chain considerations extend from monomer sourcing to polymerization capacity and post-processing capabilities, shaping how quickly novel PLA-based solutions progress from bench to bedside. These converging forces underscore the importance of a cohesive strategy that aligns material selection with device design intent, clinical evidence generation, and scalable manufacturing approaches.

This introduction frames the subsequent analysis by emphasizing the dual imperatives of technical robustness and regulatory readiness. By positioning material attributes alongside manufacturing realities and clinical needs, stakeholders can prioritize investments and collaborations that reduce translational risk and accelerate adoption in targeted therapeutic areas.

Transformative shifts redefining supply chains, innovation pipelines, and clinical adoption pathways for resorbable polylactic acid materials across healthcare sectors

The landscape for resorbable polylactic acid materials is undergoing transformative shifts driven by innovation in processing technologies, evolving clinical expectations, and strategic reconfiguration of supply chains. Additive manufacturing and precision extrusion are enabling complex geometries and porous architectures that were previously infeasible, supporting more personalized implants and scaffold constructs with controlled degradation kinetics. Simultaneously, the convergence of polymer chemistry improvements and advanced sterilization techniques is reducing device variability and broadening indications where resorbable materials can safely perform.

On the clinical front, practitioners are increasingly seeking implants and wound closure systems that reduce the need for secondary procedures and minimize long-term foreign body presence. This clinical demand is catalyzing collaboration between material scientists, device engineers, and clinicians to co-design solutions validated through robust preclinical models and targeted clinical studies. From a commercial perspective, firms are reassessing vertical integration versus specialized partnerships to optimize cost, agility, and intellectual property capture across the value chain.

These shifts occur alongside heightened regulatory scrutiny around safety and traceability, prompting manufacturers to embed comprehensive biocompatibility and degradation profiling into early development stages. As a result, the adoption curve for next-generation PLA materials will depend on how quickly organizations can translate laboratory-level material performance into documented clinical reliability and scalable manufacturing processes. Stakeholders that anticipate these shifts and invest in cross-disciplinary teams will be better positioned to set technical standards and capture clinical trust.

Assessing the cumulative economic, operational, and supply chain impact of United States tariffs implemented in 2025 on resorbable polylactic acid production and distribution

The tariff measures announced in 2025 introduced a new layer of complexity to the operational calculus for manufacturers, suppliers, and device makers relying on transnational flows of monomers, specialty polymers, and finished resorbable polylactic acid components. Increased import duties and reclassification of certain polymer intermediates have impacted procurement strategies by elevating landed costs and incentivizing local sourcing or nearshoring of critical inputs. In response, procurement teams are recalibrating supplier portfolios to prioritize geographic diversification, contractual flexibility, and visibility into upstream raw material availability.

Operationally, tariff-related friction has accelerated interest in alternate manufacturing footprints and reshoring initiatives that reduce exposure to cross-border policy volatility. Companies are evaluating whether investments in local polymerization capacity, strategic stockpiling, or supplier alliances can offset the unpredictability introduced by trade measures. This reevaluation often aligns with parallel efforts to shorten lead times and establish regional quality control hubs that support faster product iterations and regulatory submissions.

Importantly, tariff effects extend beyond direct cost increases. They influence decisions on where to site final device assembly, where to conduct additively manufactured production runs, and how to structure contractual clauses related to cost pass-through and supply continuity. For many stakeholders, the cumulative impact of tariff changes in 2025 has been a catalyst to adopt more resilient and responsive supply chain architectures, integrate scenario planning into procurement, and negotiate longer-term strategic partnerships that can withstand policy-induced disruptions.

Actionable segmentation insights revealing how applications, product types, technologies, end users, and grades influence development priorities and commercialization strategies

Segmentation offers a practical framework to understand where material attributes and processing choices deliver the most value across product life cycles and end-use demands. Based on Application, the study examines Drug Delivery with its implantable devices and injectable devices, Orthopedic Devices with its pins, plates, and screws, Tissue Engineering with hydrogel and scaffold applications, and Wound Closure with staples and sutures; examining how each application imposes unique mechanical, degradation, and regulatory requirements that influence polymer selection and processing pathways. Product Type distinctions between fiber, filament, film, and pellet delineate the primary physical forms through which polylactic acid is handled, with each form presenting different opportunities for downstream manufacturing and functional performance.

Based on Technology, the analysis compares 3D printing, extrusion, injection molding, and solvent casting to reveal how processing capability shapes design freedom, tolerances, and scalability. For example, additive manufacturing enables architected porosity and patient-specific geometries, whereas injection molding and extrusion offer high-throughput production suited to standardized components. Based on End User, the study considers clinics, hospitals, pharmaceutical companies, and research institutes to understand the varying procurement cycles, quality expectations, and clinical evidence needs that purchasers impose on suppliers. Finally, Based on Grade, the differentiation between medical grade and pharmaceutical grade polymers underscores distinctions in purity requirements, documentation, and suitability for drug-contact versus structural applications.

Integrating these segmentation lenses reveals nuanced opportunity spaces: certain applications favor high-throughput pellet- and extrusion-based supply chains, while others demand filament or fiber forms paired with additive manufacturing to realize customization and complex functionalization. End users with accelerated clinical adoption pathways, such as specialized clinics or research institutes, can act as early adopters for novel device concepts, whereas hospitals and pharmaceutical companies often require more extensive validation and standardized production processes. Grade selection remains a gating factor for regulatory acceptance and product claims, making early investment in high-purity feedstock and traceable supply chains a common strategic priority.

Regional dynamics and strategic opportunities across the Americas, Europe Middle East and Africa, and Asia-Pacific for resorbable polylactic acid adoption and supply resilience

Regional dynamics materially affect strategic choices across sourcing, regulatory engagement, and clinical trial planning. In the Americas, proximity to large clinical networks and a strong ecosystem of device manufacturers supports rapid translation from bench to bedside, but stakeholders must navigate a complex reimbursement and regulatory landscape that places a premium on robust clinical evidence and post-market surveillance. In Europe Middle East & Africa, regulatory harmonization initiatives and mature medical device markets create opportunities for standardized product introductions, while pockets of emerging demand incentivize flexible manufacturing and regional partnerships that can adapt to local procurement protocols.

In the Asia-Pacific region, growth drivers include expanding medical infrastructure, a growing base of local polymer producers, and strong capabilities in additive manufacturing and contract manufacturing services. These regional differences influence choices about where to locate polymerization capacity, quality control centers, and final device assembly. For instance, manufacturing in regions with established polymer intermediates supply chains can reduce lead times for pellets and filaments, whereas regions with advanced clinical research networks may be better suited for early-stage clinical validation of novel constructs.

Taken together, regional strategy should consider not only cost and capacity but also regulatory timelines, reimbursement pathways, and access to specialized clinical expertise. Cross-regional collaboration and tiered product rollouts can allow companies to leverage regional strengths while mitigating the risks associated with regulatory variability and trade policy shifts.

Competitive intelligence on leading manufacturers, innovators, and strategic partnerships shaping the future of resorbable polylactic acid products and capabilities

Competitive dynamics in the resorbable polylactic acid space are shaped by three broad archetypes: vertically integrated manufacturers that control polymer production through device assembly, specialized suppliers focused on high-purity polymer grades and advanced processing forms, and innovative technology providers developing enabling processing technologies and formulations. Across these archetypes, differentiation increasingly hinges on the ability to demonstrate consistent material performance, documented degradation behavior, and manufacturing processes that meet regulatory expectations for traceability and sterility.

Strategic partnerships and licensing arrangements are prevalent as device makers seek to accelerate time-to-market while managing technical risk. Collaborations between polymer producers and additive manufacturing firms enable co-development of feedstocks optimized for specific printing platforms, while alliances with contract manufacturers support scale-up from pilot to commercial volumes. Intellectual property around polymer modification, surface treatments, and controlled-release capabilities can provide defensible competitive advantage, particularly when coupled with clinical evidence that substantiates improved patient outcomes.

Investment patterns point to a focus on process control, quality systems, and regulatory science capabilities. Companies that bolster their regulatory affairs teams and build robust analytical packages for degradation, biocompatibility, and sterilization compatibility are better positioned to secure procurement contracts and clinical adoption. For many organizations, the strategic imperative is to combine material science leadership with manufacturing excellence and targeted clinical partnerships to translate innovation into widely adopted medical solutions.

Practical, prioritized recommendations for industry leaders to accelerate innovation, mitigate supply risks, and optimize clinical adoption pathways for resorbable polylactic acid

Industry leaders should prioritize a set of pragmatic actions to accelerate adoption and reduce translational friction. First, align material development with intended clinical use cases early in the design process to ensure that polymer properties, processing methods, and sterilization approaches are validated against clinical performance criteria. This front-loaded alignment reduces redesign cycles and shortens regulatory pathways when clinical evidence is generated.

Second, diversify supply chains geographically and contractually to reduce exposure to single-source disruptions and trade policy shifts. Establishing regional polymerization or compounding capabilities, combined with rigorous supplier qualification and inventory strategies, can improve resilience without sacrificing quality. Third, invest in modular manufacturing platforms and cross-validated processing protocols that enable rapid shifts between production modes such as extrusion, injection molding, and additive manufacturing; this flexibility supports both customization and scale.

Fourth, cultivate strategic clinical partnerships that provide early-stage evidence of safety and functional performance, leveraging research institutes and specialized clinics as pilot sites while preparing for larger hospital-based studies. Fifth, strengthen regulatory engagement by developing comprehensive degradation, biocompatibility, and traceability data packages and by participating in standards development where possible. Finally, consider strategic IP and licensing approaches that protect core innovations while enabling broader adoption through partnerships and co-development agreements. Executing these recommendations in parallel, with clear accountability and timelines, will increase the probability of successful commercialization and clinical uptake.

Transparent research methodology detailing data sources, qualitative and quantitative techniques, and validation approaches used to analyze resorbable polylactic acid industry dynamics

The research methodology combines systematic review of peer-reviewed literature, analysis of regulatory guidance documents, and qualitative interviews with subject-matter experts across materials science, device engineering, clinical practice, and supply chain management. Primary research included structured interviews with R&D leads, quality and regulatory professionals, and procurement specialists to capture real-world constraints and decision criteria that shape development and commercial strategy. Secondary sources comprised technical publications, standards bodies' guidance, and public regulatory filings to triangulate evidence on material properties, processing behavior, and documented clinical outcomes.

Analytical techniques included cross-sectional synthesis of technological capabilities against application requirements, scenario analysis to evaluate supply chain resilience under policy shifts, and capability mapping to identify gaps between current manufacturing practices and clinical evidence generation needs. Validation was achieved through iterative reviews with industry experts and through comparison of documented case studies that illustrate successful translation pathways. Throughout the research process, emphasis was placed on traceability of sources, reproducibility of analytical steps, and transparency in assumptions so that findings can be interrogated and applied to a range of strategic decisions.

This mixed-methods approach ensures that the conclusions and recommendations are grounded in technical reality, informed by practical constraints, and validated by those working at the interface of material science and clinical application.

Conclusive synthesis of strategic imperatives for stakeholders to align material innovation and regulatory pathways to accelerate clinical integration of resorbable polylactic acid

The synthesis underscores three interrelated imperatives for stakeholders seeking to harness the potential of resorbable polylactic acid materials: technical rigor, supply chain resilience, and regulatory alignment. Technical rigor involves establishing reproducible polymer properties and processing protocols that translate into predictable in vivo performance. This requires investment in analytical characterization, degradation profiling, and process controls that are documented early and maintained through scale-up.

Supply chain resilience means diversifying sources, shortening critical lead times where feasible, and embedding contractual mechanisms that protect against policy and market volatility. Organizations that couple supply-side robustness with adaptive manufacturing capabilities will be better equipped to respond to evolving clinical requirements and to scale production without compromising quality. Regulatory alignment is the connective tissue that ties technical and commercial efforts together; proactive engagement with regulators and participation in standards development can streamline submission pathways and support broader clinical adoption.

Together, these imperatives create a practical framework for converting material science advances into clinically meaningful products. Stakeholders who coordinate investments across these dimensions and maintain a clear line of sight from material properties to patient outcomes will create the strongest foundation for durable competitive advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Resorbable Polylactic Acid Material Market, by Product Type

  • 8.1. Fiber
  • 8.2. Filament
  • 8.3. Film
  • 8.4. Pellet

9. Resorbable Polylactic Acid Material Market, by Technology

  • 9.1. 3D Printing
  • 9.2. Extrusion
  • 9.3. Injection Molding
  • 9.4. Solvent Casting

10. Resorbable Polylactic Acid Material Market, by Grade

  • 10.1. Medical Grade
  • 10.2. Pharmaceutical Grade

11. Resorbable Polylactic Acid Material Market, by End User

  • 11.1. Clinics
  • 11.2. Hospitals
  • 11.3. Pharmaceutical Companies
  • 11.4. Research Institutes

12. Resorbable Polylactic Acid Material Market, by Application

  • 12.1. Drug Delivery
    • 12.1.1. Implantable Devices
    • 12.1.2. Injectable Devices
  • 12.2. Orthopedic Devices
    • 12.2.1. Pins
    • 12.2.2. Plates
    • 12.2.3. Screws
  • 12.3. Tissue Engineering
    • 12.3.1. Hydrogel
    • 12.3.2. Scaffold
  • 12.4. Wound Closure
    • 12.4.1. Staples
    • 12.4.2. Sutures

13. Resorbable Polylactic Acid Material Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Resorbable Polylactic Acid Material Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Resorbable Polylactic Acid Material Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Resorbable Polylactic Acid Material Market

17. China Resorbable Polylactic Acid Material Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Chongqing Jindan Bio-Technology Co., Ltd.
  • 18.6. Corbion N.V.
  • 18.7. Evonik Industries AG
  • 18.8. FKuR Kunststoff GmbH
  • 18.9. Mitsui Chemicals, Inc.
  • 18.10. NatureWorks LLC
  • 18.11. Shenzhen Esun Industrial Co., Ltd.
  • 18.12. Synbra Technology N.V.
  • 18.13. TotalEnergies Corbion B.V.
  • 18.14. Unitika Ltd.
  • 18.15. Zhejiang Hisun Biomaterials Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY FIBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY FIBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY FIBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY FILAMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY FILAMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY FILAMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY FILM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY FILM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY FILM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PELLET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PELLET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PELLET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY 3D PRINTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY 3D PRINTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY 3D PRINTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY EXTRUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SOLVENT CASTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SOLVENT CASTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SOLVENT CASTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY MEDICAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY MEDICAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY MEDICAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PHARMACEUTICAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PHARMACEUTICAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PHARMACEUTICAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY IMPLANTABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY IMPLANTABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY INJECTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY INJECTABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY INJECTABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PLATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PLATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PLATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SCREWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SCREWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SCREWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY HYDROGEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY HYDROGEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY HYDROGEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SCAFFOLD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SCAFFOLD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SCAFFOLD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY STAPLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY STAPLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY STAPLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 184. GCC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. GCC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. GCC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. GCC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 188. GCC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. GCC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. GCC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 191. GCC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 192. GCC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 193. GCC RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 214. G7 RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. G7 RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. G7 RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. G7 RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 218. G7 RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. G7 RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. G7 RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 221. G7 RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 222. G7 RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 223. G7 RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 224. NATO RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. NATO RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. NATO RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. NATO RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 228. NATO RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. NATO RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. NATO RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 231. NATO RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 232. NATO RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 233. NATO RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY ORTHOPEDIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA RESORBABLE POLYLACTIC ACID MATERIAL MARKET SIZE, BY WOUND CLOSURE, 2018-2032 (USD MILLION)